Mercy BioAnalytics, Inc. — Form D
Mercy BioAnalytics, Inc. of NATICK, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-01. The offering totals $27.3M, of which $27.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-02-01
- Form: D
- Accession: 0001842887-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $27.3M
- Amount sold: $27.3M
- Investors: 57
- Date of first sale: 2020-11-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-387942
Issuer
- Name: Mercy BioAnalytics, Inc.
- CIK: 0001842887
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 22 STRATHMORE ROAD #415, NATICK, MA, 01760
- Phone: 480-540-5566
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Paul Blavin | Director | Natick, MA |
| Stanley Lapidus | Director | BOSTON, MA |
| Paul Meister | Director | Waltham, MA |
| Sonja Hoel Perkins | Director | Natick, MA |
| Joseph Sedlak | Director | Natick, MA |
| Paul Blavin | Executive Officer | Natick, MA |
| Joseph Sedlak | Executive Officer | Natick, MA |
More